info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Porokeratosis Companies

Porokeratosis is a skin disorder characterized by the development of small, raised bumps with a surrounding ridge-like border. These lesions are known as cornoid lamellae and are a result of abnormal keratinization of the skin. While there may not be specific companies solely dedicated to porokeratosis, there are pharmaceutical and biotechnology companies that focus on dermatology and skin-related conditions, including porokeratosis. 

Porokeratosis Treatment Market

 


Latest Porokeratosis Companies Updates:


Aurinia Pharmaceuticals acquires Dermavant Sciences: This June 2023 deal strengthens Aurinia's pipeline with Dermavant's ASN-007, a promising drug for DSPPK, a severe form of porokeratosis.


PharmAust Limited partners with the University of Queensland: This collaboration aims to develop PXT3003, a potential long-term treatment for porokeratosis, with the University's expertise in skin biology and drug development.


Alma Lasers introduces Pixel CO2 laser for porokeratosis treatment: This December 2023 launch offers a minimally invasive option for treating localized porokeratosis lesions.


BioPhotas develops a novel photodynamic therapy system for porokeratosis: This technology utilizes light and photosensitive agents to target and destroy porokeratosis lesions.Companies are exploring the potential of artificial intelligence (AI) for porokeratosis diagnosis and personalized treatment recommendations.


List of Porokeratosis Key companies in the market:



  • Angiodynamics, Inc. (U.S.)

  • Allergan (Republic of Ireland)

  • Alma Lasers (Israel)

  • Beiersdorf AG (Germany)

  • Biogen (U.S.)

  • Biolase Inc. (U.S.)

  • Coherent, Inc. (U.S.)

  • Coty Inc. (U.S.)

  • Cutera (U.S.)

  • Danaher Corporation (U.S.)

  • F. Hoffmann-La Roche Ltd (Switzerland)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.